Nothing Special   »   [go: up one dir, main page]

La Fata et al., 2014 - Google Patents

Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease

La Fata et al., 2014

View HTML
Document ID
10088722946164416730
Author
La Fata G
Weber P
Mohajeri M
Publication year
Publication venue
Nutrients

External Links

Snippet

Vitamin E is an important antioxidant that primarily protects cells from damage associated with oxidative stress caused by free radicals. The brain is highly susceptible to oxidative stress, which increases during ageing and is considered a major contributor to …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
La Fata et al. Effects of vitamin E on cognitive performance during ageing and in Alzheimer’s disease
Mielech et al. Vitamins in Alzheimer’s disease—Review of the latest reports
Harrison et al. Ascorbic acid and the brain: rationale for the use against cognitive decline
Cox et al. Further evidence of benefits to mood and working memory from lipidated curcumin in healthy older people: a 12-week, double-blind, placebo-controlled, partial replication study
Castro-Marrero et al. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a prospective, randomized, double-blind, placebo-controlled trial
Currenti et al. Association between time restricted feeding and cognitive status in older Italian adults
Rolland et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain lifestyle intervention on muscle strength in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT)
Hoepner et al. Impact of supplementation and nutritional interventions on pathogenic processes of mood disorders: A review of the evidence
Madireddy et al. Regulation of reactive oxygen species-mediated damage in the pathogenesis of schizophrenia
Sanchez-Morate et al. Relationship between diet, microbiota, and healthy aging
Cordaro et al. Key mechanisms and potential implications of Hericium erinaceus in NLRP3 inflammasome activation by reactive oxygen species during Alzheimer’s disease
Díaz et al. Analgesic and antidepressant effects of oltipraz on neuropathic pain in mice by modulating microglial activation
Alvarez-Mon et al. Exploring the role of nutraceuticals in major depressive disorder (MDD): Rationale, state of the art and future prospects
Tsoukalas et al. A novel nutraceutical formulation can improve motor activity and decrease the stress level in a murine model of middle-age animals
Izquierdo et al. Resveratrol supplementation attenuates cognitive and molecular alterations under maternal high-fat diet intake: epigenetic inheritance over generations
Li et al. Folic acid inhibits amyloid β-peptide production through modulating DNA methyltransferase activity in N2a-APP cells
Katonova et al. Effect of a vegan diet on Alzheimer’s disease
Pechanova et al. Chronic L-Name-treatment produces hypertension by different mechanisms in peripheral tissues and brain: Role of central eNOS
Lee et al. The potential of N-acetylcysteine for treatment of trichotillomania, excoriation disorder, onychophagia, and onychotillomania: An updated literature review
Scala et al. Epigallocatechin-3-gallate plus omega-3 restores the mitochondrial complex I and F0F1-ATP synthase activities in PBMCs of young children with Down syndrome: a pilot study of safety and efficacy
Carillon et al. Dietary supplementation with a superoxide dismutase-melon concentrate reduces stress, physical and mental fatigue in healthy people: A randomised, double-blind, placebo-controlled trial
Choi et al. The effects of spirulina maxima extract on memory improvement in those with mild cognitive impairment: A randomized, double-Blind, placebo-controlled clinical trial
Platero et al. The impact of epigallocatechin gallate and coconut oil treatment on cortisol activity and depression in multiple sclerosis patients
Rosi et al. Use of non-pharmacological supplementations in children and adolescents with attention deficit/hyperactivity disorder: A critical review
Chen et al. Alcalase potato protein hydrolysate-PPH902 enhances myogenic differentiation and enhances skeletal muscle protein synthesis under high glucose condition in C2C12 cells